Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

Article ID	Journal	Published Year	Pages	File Type
1968916	Clinical Biochemistry	2014	7 Pages	PDF

Keywords

RT-PCR National Cholesterol Education Program-Adult Treatment Panel III TNF NCEP-ATPIII MDRD OPG ΔCT FOV IMT RANKL HDL CAC Atherosclerosis Osteoprotegerin modification of diet in renal disease electrocardiogram ECG standard deviation Adipose tissue computed tomography Rank Real-time reverse transcriptase-polymerase chain reaction Metabolic syndrome body mass index BMI Intima-media thickness tumor necrosis factor high density lipoprotein low density lipoprotein LDL Field of view Hounsfield units polymerase chain reaction PCR coronary calcification coronary artery calcium

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry

Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

Authors

Carmen Pérez de Ciriza, MarÃa Moreno, Patricia Restituto, Gorka Bastarrika, Isabel Simón, Inmaculada Colina, Nerea Varo,